The work of the Tang Prize winners in biopharmaceutical science has revolutionized the genome editing platform, making it programmable like never before, and could help tackle complicated human diseases, both scholars and Tang Prize Selection Committee members said on Sunday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Culture
Veteran Taiwanese poet Lee Kuei-shien dies at 87
01/16/2025 06:53 PM - Business
TSMC aims to build supply chain in U.S. to cut costs
01/16/2025 06:45 PM - Business
TSMC forecasts 2025 sales growth of up to 26%
01/16/2025 06:21 PM - Politics
Government decries massive budget cuts proposed by KMT, TPP
01/16/2025 06:05 PM - Business